Evogene Ltd
NASDAQ:EVGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Samvardhana Motherson International Ltd
NSE:MOTHERSON
|
IN |
|
S
|
Sigachi Industries Ltd
NSE:SIGACHI
|
IN |
|
L
|
Leon Technology Co Ltd
SZSE:300603
|
CN |
|
Christian Berner Tech Trade AB
STO:CBTT B
|
SE |
|
H
|
Hong Seng Consolidated Bhd
KLSE:HONGSENG
|
MY |
|
J
|
J C T Ltd
BSE:500223
|
IN |
|
Maha Energy AB
STO:MAHA A
|
SE |
|
Iochpe Maxion SA
BOVESPA:MYPK3
|
BR |
|
Huanlejia Food Group Co Ltd
SZSE:300997
|
CN |
Evogene Ltd
Other Liabilities
Evogene Ltd
Other Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Evogene Ltd
NASDAQ:EVGN
|
Other Liabilities
$3.1m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
0%
|
|
|
Kamada Ltd
NASDAQ:KMDA
|
Other Liabilities
$51.2m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
72%
|
CAGR 10-Years
23%
|
|
|
Enlivex Therapeutics Ltd
NASDAQ:ENLV
|
Other Liabilities
$426k
|
CAGR 3-Years
-55%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
24%
|
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Other Liabilities
$133.8m
|
CAGR 3-Years
9%
|
CAGR 5-Years
100%
|
CAGR 10-Years
N/A
|
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Other Liabilities
$602k
|
CAGR 3-Years
147%
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
|
Pluri Inc
NASDAQ:PLUR
|
Other Liabilities
$6.8m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
43%
|
CAGR 10-Years
13%
|
|
Evogene Ltd
Glance View
Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
See Also
What is Evogene Ltd's Other Liabilities?
Other Liabilities
3.1m
USD
Based on the financial report for Dec 31, 2025, Evogene Ltd's Other Liabilities amounts to 3.1m USD.
What is Evogene Ltd's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
0%
Over the last year, the Other Liabilities growth was -29%. The average annual Other Liabilities growth rates for Evogene Ltd have been -13% over the past three years , -3% over the past five years .
